首页> 外文期刊>Annals of Surgery >The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?
【24h】

The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?

机译:体重指数对心脏移植术后生存的影响:预后是否支持共识指南?

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To determine the relationship between body mass index (BMI) at the time of transplant and posttransplant survival and morbidity. SUMMARY BACKGROUND DATA: The recent International Society for Heart and Lung Transplantation listing criteria for heart transplantation stated that candidates should achieve a BMI <30 kg/m-or percent ideal body weight <140%-before listing for cardiac transplantation. However, data to support these recommendations are limited and often conflicting. METHODS: United Network of Organ Sharing provided de-identified patient-level data. Analysis included 19,593 orthotopic heart transplant recipients aged >or=18 years and transplanted January 1 1995-December 31 2005. Follow-up data were provided through February 8, 2008. Recipients were stratified by BMI at the time of transplantation: BMI <18.5 (underweight), 18.5 to 24.99 (normal weight), 25 to 29.99 (overweight), 30 to 34.99 (obesity class I), and >or=35 (obesity class II/III). The primary outcome measure was post-transplant survival. RESULTS: Risk-adjusted median survival in the underweight, normal weight, overweight, obesity I, and obesity II/III groups was 8.31, 10.20, 10.03, 9.51, and 9.05 years, respectively. In multivariate Cox proportional hazards regression, BMI in the overweight (HR = 1.08, 0.99-1.17; P = 0.055) and obesity I (HR = 1.05, 0.99-1.12; P = 0.091) ranges were not associated with significantly diminished survival. However, BMI in the underweight (HR = 1.26, 1.11-1.43; P < 0.001) and obesity II/III (HR = 1.18, 1.01-1.38; P = 0.030) ranges were associated with diminished posttransplant survival. CONCLUSION: Findings from this analysis do not suggest that obesity I (BMI of 30-34.99) is associated with significantly higher morbidity and mortality. However, underweight and obesity II/III recipients have significantly higher morbidity and mortality compared with other groups.
机译:目的:确定移植时的体重指数(BMI)与移植后生存率和发病率之间的关系。摘要背景数据:国际心脏和肺移植国际协会最近列出的心脏移植标准指出,候选人应在心脏移植之前达到BMI <30 kg / m或理想体重百分比<140%。但是,支持这些建议的数据是有限的,并且经常会发生冲突。方法:器官共享联合网络提供了身份不明的患者水平数据。分析包括19593例年龄≥18岁的原位心脏移植受者,并于1995年1月1日至2005年12月31日进行了移植。随访数据截止至2008年2月8日。接受者在移植时按BMI进行分层:BMI <18.5(体重不足),18.5至24.99(正常体重),25至29.99(超重),30至34.99(肥胖等级I)和>或= 35(肥胖等级II / III)。主要结果指标是移植后的存活率。结果:体重不足,正常体重,超重,肥胖I和肥胖II / III组经风险调整的中位生存期分别为8.31、10.20、10.03、9.51和9.05年。在多元Cox比例风险回归中,超重(HR = 1.08,0.99-1.17; P = 0.055)和肥胖I(HR = 1.05,0.99-1.12; P = 0.091)范围内的BMI与生存率显着降低无关。然而,体重不足(HR = 1.26,1.11-1.43; P <0.001)和肥胖症的II / III(HR = 1.18,1.01-1.38; P = 0.030)的BMI与移植后生存期缩短有关。结论:该分析的结果并不表明肥胖I(BMI为30-34.99)与发病率和死亡率显着相关。然而,与其他人群相比,体重不足和肥胖的II / III接受者的发病率和死亡率显着更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号